Aesthetic concerns related to rapid weight loss have come under renewed attention with the emergence of so-called "Ozempic face," a condition marked by sagging skin and changes in facial contours after using the medication Ozempic for weight management. Ozempic, a drug prescribed to assist with weight loss, has been associated with a loss of facial fat that can lead to a gaunt appearance and sagging skin, particularly among middle-aged individuals.

A recent personal account highlights the challenges and solutions tied to these physical changes. The individual, who began using Ozempic in April 2023 to address health issues including prediabetes, high cholesterol, and back pain, reported a significant weight loss of approximately 7 kilograms (around 15 pounds) over six months. Despite the health benefits and improved confidence that came with the weight reduction, the user noticed marked changes in her facial appearance, including lumps under the eyes and crepey skin on her neck.

Experts attribute these changes to the loss of underlying facial fat pads, which normally provide cushioning and support to the skin. Dermatologist Dr. Lindsey Bordone explains that rapid weight loss often exposes fine lines and loose skin, a process that is further pronounced with aging. In cases where facial fillers have been previously applied, the shrinking fat can cause fillers to migrate, resulting in visible irregularities.

To address these issues, the individual sought treatment from cosmetic specialists in London. At Dr MediSpa in Knightsbridge, Dr. Munir Somji used ultrasound imaging to assess the under-eye area and identified that the migrated filler was causing the lumps. He recommended an enzymatic treatment with hyaluronidase to dissolve the displaced filler, resulting in immediate improvement.

For further rejuvenation, the individual received a Radiesse wash administered by cosmetic doctor Dr. Paris Acharya. Radiesse, a gel filler containing calcium hydroxylapatite particles, is used in a diluted form to stimulate collagen production and enhance skin quality rather than add volume. The treatment aims to rebuild structural support beneath the skin, particularly effective in delicate areas such as the neck, which is prone to sagging due to its thin skin. The individual reported visible improvements following a single treatment, with optimal results typically developing over six weeks and lasting up to 18 months.

In addition to clinical treatments, attention has turned to emerging skincare ingredients. Volufiline, a compound extracted from the Chinese plant anemarrhena, has gained traction as a topical agent to combat facial volume loss. Originally used in body creams with limited popularity, Volufiline has been repurposed in serums targeting "Ozempic face." British chemical company Croda, which manufactures the ingredient, has experienced a surge in market interest, with multiple global beauty brands incorporating it into their products.

This combination of medical and topical interventions offers hope for individuals seeking to manage the aesthetic side effects of rapid weight loss. While weight reduction remains a key health goal for many, experts and patients alike emphasize that maintaining skin quality and facial volume can be achieved without sacrificing body goals. Appropriate cosmetic treatments and innovative skincare solutions may help those affected balance overall wellness with appearance concerns.